title: [Therapeutic strategy for cervicofacial lymphangioma in children].
abstract: The authors report a series of 22 cervicofacial lymphagiomas treated from 1984 to 1990, and try to define a therapeutic strategy. In 11 cases, facial, laryngeal or pharyngeal extension was observed, and 1 cas showed mediastinal extension. These cases are not easily treated, and it is impossible to perform complete surgery, thus leading to recurrence. Tracheotomy was necessary in two cases. In 5 cases, the extension was limited to the cervical area and surgical exeresis was considered complete. Sclerosing injections gave variable results.
authors.affiliation: Service ORL et de Chirurgie Cervico-Faciale, Hôpital Trousseau, Paris.
authors.forename: P
authors.initials: P
authors.lastname: Roelly
authors.forename: E N
authors.initials: EN
authors.lastname: Garabedian
authors.forename: P
authors.initials: P
authors.lastname: Attal
authors.forename: F
authors.initials: F
authors.lastname: Denoyelle
authors.forename: G
authors.initials: G
authors.lastname: Tashjian
mesh_terms: D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D003973:Diatrizoate; D004338:Drug Combinations; D005153:Facial Neoplasms / Q000601:surgery / Q000628:therapy*; D005227:Fatty Acids; D005260:Female; D006258:Head and Neck Neoplasms / Q000601:surgery / Q000628:therapy*; D006801:Humans; D007223:Infant; D008202:Lymphangioma / Q000601:surgery / Q000628:therapy*; D008297:Male; D009364:Neoplasm Recurrence, Local; D011409:Propylene Glycols; D011506:Proteins / Q000627:therapeutic use*; D012189:Retrospective Studies; D012597:Sclerosing Solutions / Q000627:therapeutic use*; D015028:Zein
chemical_list: D004338:Drug Combinations; D005227:Fatty Acids; D011409:Propylene Glycols; D011506:Proteins; D012597:Sclerosing Solutions; D003973:Diatrizoate; D015028:Zein; C020481:alcoholic prolamine solution
vernacular_title: Attitude thérapeutique devant les lymphangiomes cervico-faciaux de l'enfant.